AI assistant
Sending…
Cardlytics, Inc. — Director's Dealing 2018
Feb 15, 2018
33956_dirs_2018-02-15_702de500-05ea-476c-bb2b-6ccc21bbd3f2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cardlytics, Inc. (CDLX)
CIK: 0001666071
Period of Report: 2018-02-13
Reporting Person: Klinck John L. Jr. (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-02-13 | Common Stock | C | 5801 | — | Acquired | 5801 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-02-13 | Series G Redeemable Convertible Preferred Stock | $ | C | 5801 | Disposed | Common Stock (5801) | Direct |
Footnotes
F1: Each share of Series G Redeemable Convertible Preferred Stock converted into the Issuer's Common Stock on a one-for-one basis upon the Issuer's initial public offering and has no expiration date.
More from Cardlytics, Inc.
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 7
Annual Report
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Annual Report
2026
Mar 4
Regulatory Filings
2026
Mar 4
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 20
Director's Dealing
2026
Feb 19
Regulatory Filings
2026
Jan 26